Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD

PURPOSE: This study investigated the efficacy, safety, and pharmacokinetics of the inhaled corticosteroid/long-acting β(2)-agonist fixed-dose combination budesonide/formoterol fumarate (BFF) metered dose inhaler (MDI), compared with the monocomponents budesonide (BD) MDI and formoterol fumarate (FF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerwin, Edward M, Siler, Thomas M, Arora, Samir, Darken, Patrick, Rose, Earl, Reisner, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947839/
https://www.ncbi.nlm.nih.gov/pubmed/29773947
http://dx.doi.org/10.2147/COPD.S164281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947839/
https://www.ncbi.nlm.nih.gov/pubmed/29773947
http://dx.doi.org/10.2147/COPD.S164281

Ejemplares similares